Logo image of FMS

FRESENIUS MEDICAL CARE-ADR (FMS) Stock Analyst Ratings

USA - New York Stock Exchange - NYSE:FMS - US3580291066 - ADR

23.92 USD
+0.1 (+0.42%)
Last: 11/28/2025, 7:31:48 PM
Buy % Consensus

66

ChartMill assigns a Buy % Consensus number of 66% to FMS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 28.01. This target is 17.09% above the current price.
FMS was analyzed by 25 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about FMS.
In the previous month the buy percentage consensus was at a similar level.
FMS was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

FMS Historical Analyst RatingsFMS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 10 20 30

Price Target & Forecast

Price Low Median Mean High 23.9214.1328.7528.0137.64 - -40.91% 20.21% 17.09% 57.37%

Related screens

FMS Current Analyst RatingFMS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-09-02 UBS Downgrade Neutral -> Sell
2025-05-12 Truist Securities Maintains Hold -> Hold
2025-01-06 Truist Securities Maintains Hold -> Hold
2024-10-07 Truist Securities Maintains Hold -> Hold
2024-07-31 Truist Securities Maintains Hold -> Hold
2024-05-15 Truist Securities Maintains Hold -> Hold
2023-11-24 HSBC Upgrade Reduce -> Hold
2023-10-11 Truist Securities Maintains Hold -> Hold
2023-07-13 Truist Securities Maintains Hold -> Hold
2023-05-10 Truist Securities Maintains Hold -> Hold
2023-04-13 Truist Securities Maintains Hold
2023-02-23 Truist Securities Maintains Hold
2022-06-22 Truist Securities Maintains Hold
2021-11-23 HSBC Initiate Hold
2021-11-17 RBC Capital Maintains Sector Perform
2021-11-11 Jefferies Upgrade Underperform -> Hold
2021-08-11 JPMorgan Chase Initiate
2021-08-06 Goldman Sachs Initiate
2021-07-24 Jefferies Initiate
2021-07-23 Jefferies Initiate
2021-07-22 Goldman Sachs Initiate
2021-07-21 Goldman Sachs Initiate
2021-07-20 JPMorgan Chase Initiate
2021-07-20 Berenberg Bank Initiate
2021-07-14 Morgan Stanley Initiate
2021-06-07 Goldman Sachs Initiate Buy
2021-06-07 Jefferies Initiate Sell
2021-06-01 Goldman Sachs Initiate Buy
2021-05-12 Nord/LB Initiate Buy
2021-05-12 JPMorgan Chase Initiate Neutral

FRESENIUS MEDICAL CARE-ADR / FMS FAQ

What is the price target for FMS stock?

25 analysts have analysed FMS and the average price target is 28.01 USD. This implies a price increase of 17.09% is expected in the next year compared to the current price of 23.92.


What is the consensus rating for FRESENIUS MEDICAL CARE-ADR (FMS) stock?

The consensus rating for FRESENIUS MEDICAL CARE-ADR (FMS) is 65.6 / 100 . This indicates that analysts generally have a neutral outlook on the stock.